2,853
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Protective effects of vitamin D3 (cholecalciferol) on vancomycin-induced oxidative nephrotoxic damage in rats

, &
Pages 755-766 | Received 09 Aug 2022, Accepted 13 Apr 2023, Published online: 04 May 2023

References

  • Ahmida MH. 2012. Protective role of curcumin in nephrotoxic oxidative damage induced by vancomycin in rats. Exp Toxicol Pathol. 64(3):149–153.
  • Annouf Y, Al Laham S, Chatty E. 2020. Effect of amlodipine combined with N-acetylcysteine on Crohn’s disease model in rats. IJPSM. 5(11):1–12.
  • Annweiler C, Hanotte B, Grandin de l‘Eprevier C, Sabatier J-M, Lafaie L, Célarier T. 2020. Vitamin D and survival in COVID-19 patients: a quasi-experimental study. J Steroid Biochem Mol Biol. 204:105771.
  • Appel GB, Given DB, Levine LR, Cooper GL. 1986. Vancomycin and the kidney. Am J Kidney Dis. 8(2):75–80.
  • Arimura Y, Yano T, Hirano M, Sakamoto Y, Egashira N, Oishi R. 2012. Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. Free Radic Biol Med. 52(9):1865–1873.
  • Aronoff GR, Sloan R, Dinwiddie JC, Glant M, Fineberg N, Luft F. 1981. Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother. 19(2):306–308.
  • Basarslan F, Yilmaz N, Ates S, Ozgur T, Tutanc M, Motor VK, Arica V, Yilmaz C, Inci M, Buyukbas S. 2012. Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats. Hum Exp Toxicol. 31(7):726–733.
  • Beauchamp D, Pellerin M, Gourde P, Pettigrew M, Bergeron MG. 1990. Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats. Antimicrob Agents Chemother. 34(1):139–147.
  • Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. 2008. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 29(6):726–776.
  • Cashman KD, Kinsella M, Mcnulty BA, Walton J, Gibney MJ, Flynn A, Kiely M. 2014. Dietary vitamin D2–a potentially underestimated contributor to vitamin D nutritional status of adults? Br J Nutr. 112(2):193–202.
  • Celik I, Cihangiroglu M, Ilhan N, Akpolat N, Akbulut HH. 2005. Protective effects of different antioxidants and amrinone on vancomycin‐induced nephrotoxicity. Basic Clin Pharmacol Toxicol. 97(5):325–332.
  • Cetin H, Olgar Ş, Oktem F, Ciris M, Uz E, Aslan Ç, Ozguner F. 2007. Novel evidence suggesting an anti‐oxidant property for erythropoietin on vancomycin‐induced nephrotoxicity in a rat model. Clin Exp Pharmacol Physiol. 34(11):1181–1185.
  • Cli Y. 2011. Podocytes as target of vitamin D. Curr Diabetes Rev. 7:35–40.
  • Cranney A, Horsley T, O'donnell S, Weiler H, Puil L, Ool D, Atkinson S, Ward L, Moher D, Hanley D. 2007. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess. 158:1–235.
  • Cunha BA. 1995. Vancomycin. Med Clin North Am. 79(4):817–831.
  • De Jesus Soares T, Volpini RA, Francescato HD, Costa RS, Da Silva CG, Coimbra TM. 2007. Effects of resveratrol on glycerol-induced renal injury. Life Sci. 81(8):647–656.
  • Dean RT, Hunt JV, Grant AJ, Yamamoto Y, Niki E. 1991. Free radical damage to proteins: the influence of the relative localization of radical generation, antioxidants, and target proteins. Free Radic Biol Med. 11(2):161–168.
  • Deluca HF, Cantorna MT. 2001. Vitamin D: its role and uses in immunology. 1faseb J. 15(14):2579–2585.
  • Donato AJ, Pierce GL, Lesniewski LA, Seals DR. 2009. Role of NFκB in age-related vascular endothelial dysfunction in humans. Aging (Albany NY). 1(8):678–680.
  • Du J, Jiang S, Hu Z, Tang S, Sun Y, He J, Li Z, Yi B, Wang J, Zhang H, et al. 2019. Vitamin D receptor activation protects against lipopolysaccharide-induced acute kidney injury through suppression of tubular cell apoptosis. Am J Physiol Renal Physiol. 316(5):F1068–F1077.
  • Dulak J, Józkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, Florek I, Wójtowicz A, Szuba A, Cooke JP. 2000. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 20(3):659–666.
  • Elbassuoni EA, Ragy MM, Ahmed SM. 2018. Evidence of the protective effect of l-arginine and vitamin D against monosodium glutamate-induced liver and kidney dysfunction in rats. Biomed Pharmacother. 108:799–808.
  • El-Gohary OA, Allam MM. 2017. Effect of vitamin D on isoprenaline-induced myocardial infarction in rats: possible role of peroxisome proliferator-activated receptor-γ. Can J Physiol Pharmacol. 95(6):641–646.
  • Emeka PM, Rasool ST, Morsy MA, Hairul Islam MI, Chohan MS. 2021. Protective effects of lutein against vancomycin-induced acute renal injury in mice via upregulation of peroxisome proliferator activated receptor gamma/nuclear factor erythroid 2-related factor 2 and inhibition nuclear factor-kappaB/caspase 3. Korean J Physiol Pharmacol. 25(4):321–331.
  • Erdem A, Gündoğan NU, Usubütün A, Kilinç K, Erdem SR, Kara A, Bozkurt A. 2000. The protective effect of taurine against gentamicin‐induced acute tubular necrosis in rats. Nephrol Dial Transplant. 15(8):1175–1182.
  • Feghali CA, Wright TM. 1997. Cytokines in acute and chronic inflammation. Front Biosci. 2:d12–d26.
  • Finch JL, Suarez EB, Husain K, Ferder L, Cardema MC, Glenn DJ, Gardner DG, Liapis H, Slatopolsky E. 2012. Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats. Am J Physiol Renal Physiol. 302(1):F141–F149.
  • George N, Kumar TP, Antony S, Jayanarayanan S, Paulose CS. 2012. Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats. Br J Nutr. 108(8):1410–1418.
  • Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC. 2006. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 98(7):451–459.
  • Gren A. 2013. Effects of vitamin E, C and D supplementation on inflammation and oxidative stress in streptozotocin-induced diabetic mice. Int J Vitam Nutr Res. 83:168–175.
  • Holick MF. 1996. Vitamin D and bone health. J Nutr. 126(4 Suppl):1159S–1164S.
  • Hur E, Garip A, Camyar A, Ilgun S, Ozisik M, Tuna S, Olukman M, Narli Ozdemir Z, Yildirim Sozmen E, Sen S, et al. 2013. The effects of vitamin D on gentamicin-induced acute kidney injury in experimental rat model. Int J Endocrinol Metab. 2013:1–7.
  • Inoue M, Nishikawa M, Sato E, Matsuno K, Sasaki J. 1999. Synthesis of superoxide dismutase derivative that specifically accumulates in renal proximal tubule cells. Arch Biochem Biophys. 368(2):354–360.
  • Iwamoto T, Kagawa Y, Kojima M. 2003. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol Pharm Bull. 26(6):876–879.
  • Jorgensen SCJ, Murray KP, Lagnf AM, Melvin S, Bhatia S, Shamim M-D, Smith JR, Brade KD, Simon SP, Nagel J, et al. 2020. A multicenter evaluation of vancomycin-associated acute kidney injury in hospitalized patients with acute bacterial skin and skin structure infections. Infect Dis Ther. 9(1):89–106.
  • Kim DH, Meza CA, Clarke H, Kim JS, Hickner RC. 2020. Vitamin D and endothelial function. Nutrients. 12(2):575–580.
  • King D, Smith M. 2004. Proliferative responses observed following vancomycin treatment in renal proximal tubule epithelial cells. Toxicol in Vitro. 18(6):797–803.
  • Kobayashi M, Yamamoto M. 2005. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 7(3-4):385–394.
  • Li X. 2012. Improved pyrogallol autoxidation method: a reliable and cheap superoxide-scavenging assay suitable for all antioxidants. J Agric Food Chem. 60(25):6418–6424.
  • Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, et al. 2001. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol. 158(5):1733–1741.
  • Malkani N, Naeem A, Ijaz F, Mumtaz S, Ashraf S, Sohail MI. 2020. Silybum marianum (milk thistle) improves vancomycin induced nephrotoxicity by downregulating apoptosis. Mol Biol Rep. 47(7):5451–5459.
  • Martin JH, Norris R, Barras M, Roberts J, Morris R, Doogue M, Jones GR. 2010. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clin Biochem Rev. 31:21–24.
  • Mokhtari-Zaer A, Hosseini M, Salmani H, Arab Z, Zareian P. 2020. Vitamin D3 attenuates lipopolysaccharide-induced cognitive impairment in rats by inhibiting inflammation and oxidative stress. Life Sci. 253:117703.
  • Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, Andreeff M, Koeffler HP. 1996. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood. 88(6):2201–2209.
  • Nagpal S, Na S, Rathnachalam R. 2005. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 26(5):662–687.
  • Nakai K, Fujii H, Kono K, Goto S, Kitazawa R, Kitazawa S, Hirata M, Shinohara M, Fukagawa M, Nishi S. 2014. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats. Am J Hypertens. 27(4):586–595.
  • Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. 1997. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem. 43(7):1209–1214.
  • Nishino Y, Takemura S, Minamiyama Y, Hirohashi K, Ogino T, Inoue M, Okada S, Kinoshita H. 2003. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic Res. 37(4):373–379.
  • Nishino Y, Takemura S, Minamiyama Y, Hirohashi K, Tanaka H, Inoue M, Okada S, Kinoshita H. 2002. Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox Rep. 7(5):317–319.
  • Ocak S, Gorur S, Hakverdi S, Celik S, Erdogan S. 2007. Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N‐acetylcysteine on vancomycin‐induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol. 100(5):328–333.
  • Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95(2):351–358.
  • Öktem F, Arslan MK, Ozguner F, Candir Ö, Yilmaz HR, Ciris M, Uz E. 2005. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology. 215(3):227–233.
  • Pais GM, Liu J, Zepcan S, Avedissian SN, Rhodes NJ, Downes KJ, Moorthy GS, Scheetz MH. 2020. Vancomycin‐induced kidney injury: animal models of toxicodynamics, mechanisms of injury, human translation, and potential strategies for prevention. Pharmacotherapy. 40(5):438–454.
  • Qu S, Dai C, Lang F, Hu L, Tang Q, Wang H, Zhang Y, Hao Z. 2019. Rutin attenuates vancomycin-induced nephrotoxicity by ameliorating oxidative stress, apoptosis, and inflammation in rats. Antimicrob Agents Chemother. 63(1):e01545-18.
  • Reiter R, Poeggeler B, Tan-X D, Chen-D L, Manchester L, Guerrero J. 1993. Antioxidant capacity of melatonin: a novel action not requiring a receptor. Neuro Endocrinol Lett. 15:103–116.
  • Ronco C, Reis T, Husain-Syed F. 2020. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 8(7):738–742.
  • See YP, Young BE, Ang LW, Ooi XY, Chan CP, Looi WL, Yeo SC, Lye DC. 2021. Risk factors for development of acute kidney injury in COVID-19 patients: a retrospective observational cohort study. Nephron. 145(3):256–264.
  • Seif AA, Abdelwahed DM. 2014. Vitamin D ameliorates hepatic ischemic/reperfusion injury in rats. J Physiol Biochem. 70(3):659–666.
  • Sun J, Zhong W, Gu Y, Groome LJ, Wang Y. 2014. 1, 25 (OH) 2D3 suppresses COX-2 up-regulation and thromboxane production in placental trophoblast cells in response to hypoxic stimulation. Placenta. 35(2):143–145.
  • Tan X, Li Y, Liu Y. 2006. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol. 17(12):3382–3393.
  • Tan X, Li Y, Liu Y. 2007. Therapeutic role and potential mechanisms of active vitamin D in renal interstitial fibrosis. J Steroid Biochem Mol Biol. 103(3-5):491–496.
  • Tan X, Wen X, Liu Y. 2008. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor–mediated sequestration of NF-κB signaling. J Am Soc Nephrol. 19(9):1741–1752.
  • Teixeira TM, Da Costa DC, Resende AC, Soulage CO, Bezerra FF, Daleprane JB. 2017. Activation of Nrf2-antioxidant signaling by 1, 25-dihydroxycholecalciferol prevents leptin-induced oxidative stress and inflammation in human endothelial cells. J Nutr. 147(4):506–513.
  • Tohari AM, Alhasani RH, Biswas L, Patnaik SR, Reilly J, Zeng Z, Shu X. 2019. Vitamin D attenuates oxidative damage and inflammation in retinal pigment epithelial cells. Antioxidants. 8(9):341–350.
  • Vardi N, Parlakpinar H, Ozturk F, Acet A. 2005. Gentamicin‐induced nephrotoxicity and protective effect of caffeic acid phenethyl ester in rats. Fundam Clin Pharmacol. 19(2):173–177.
  • Xu S, Chen YH, Tan ZX, Xie DD, Zhang C, Zhang ZH, Wang H, Zhao H, Yu DX, Xu DX. 2015. Vitamin D3 pretreatment regulates renal inflammatory responses during lipopolysaccharide-induced acute kidney injury. Sci Rep. 5(1):13.
  • Yin L, Qi T, Chen Y, Guo M, Shi H, Fan Y, Ling Y, Tao Y, Li Y, Wang L. 2020. Pharmacokinetics and pharmacodynamics of vancomycin in severe COVID-19 patients: a preliminary study in a Chinese tertiary hospital. Research Square. 1:1–7.
  • Yucel C, Erdogan Yucel E, Arslan FD, Ekmekci S, Kisa E, Ulker V, Ucar M, Ilbey YO, Celik O, Isbilen Basok B, et al. 2019. All-trans retinoic acid prevents cisplatin-induced nephrotoxicity in rats. Naunyn Schmiedebergs Arch Pharmacol. 392(2):159–164.
  • Zella JB, Deluca HF. 2003. Vitamin D and autoimmune diabetes. J Cell Biochem. 88(2):216–222.
  • Zemmouri H, Sekiou O, Ammar S, El Feki A, Bouaziz M, Messarah M, Boumendjel A. 2017. Urtica dioica attenuates ovalbumin-induced inflammation and lipid peroxidation of lung tissues in rat asthma model. Pharm Biol. 55(1):1561–1568.
  • Zhong W, Gu B, Gu Y, Groome LJ, Sun J, Wang Y. 2014. Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells. J Steroid Biochem Mol Biol. 140:56–62.